Skip to main content

Table 2 Growth inhibitory effect of Cisplatin (ID50) with and without CCI-779

From: Overcoming cisplatin resistance by mTOR inhibitor in lung cancer

  Cisplatin (ug/ml) Cisplatin (ug/ml)+ CCI-779
SCLC1 0.15 ± 0.05 0.18 ± 0.02
SR-2 2.52 ± 0.51 0.45 ± 0.03
SCLCB 0.25 ± 0.12 0.14 ± 0.02
SCLCBC 2.57 ± 0.23 0.55 ± 0.04
SCLCL 0.95 ± 0.08 0.3 0 ± 0. 05
NSCLCW 1.2 ± 0.07 0.28 ± 0.04
NSCLCG 1.5 ± 0.5 0.4 ± 0.07